Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05305729
Other study ID # MetaPrint-2021
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2021
Est. completion date March 2026

Study information

Verified date March 2022
Source Arcensus GmbH
Contact Volha Skrahina, PhD
Phone +49 172 4182235
Email volha.skrahina@arcensus-diagnostics.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing treatment of genetic diseases.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date March 2026
Est. primary completion date March 2026
Accepts healthy volunteers No
Gender All
Age group 2 Months and older
Eligibility Inclusion Criteria: - Informed consent is obtained from the participant or from the parent/ legal guardian - The participant is 2 months or older - The participant is diagnosed with a genetic disease - The participant is a first degree relative of a subject diagnosed with a genetic disease Exclusion Criteria: - Informed consent is not obtained from the participant or from the parent/ legal guardian - The participant is younger than 2 months - The participant is not diagnosed with a genetic disease - The participant is not a first degree relative of a subject diagnosed with a genetic disease

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervention

Locations

Country Name City State
Albania University Hospital Center Mother Teresa Tirana
Pakistan Pakistan Institute of Medical Sciences (PIMS) Islamabad
Pakistan The Children's hospital & Institute of child health Lahore Punjab
Pakistan Children's Hospital & The Institute of Child Health Multan
Pakistan Khyber institute of Child Health and Children Hospital (KICH) Peshawar

Sponsors (1)

Lead Sponsor Collaborator
Arcensus GmbH

Countries where clinical trial is conducted

Albania,  Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of newly identified, disease-specific Metabolic Fingerprints Plasma-derived metabolite profiles that are specific for a particular genetic disease in comparison to healthy controls and other genetic diseases 5 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT03292302 - Phase 1 Study of ELX-02 in Healthy Adults Phase 1
Withdrawn NCT03658382 - Virtual Visits for Results Disclosure N/A
Recruiting NCT02266615 - Biobank Clinical Genetics Maastricht (KG01)
Recruiting NCT02450851 - Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Recruiting NCT05472714 - Educational Video for Genetic Testing N/A
Recruiting NCT04285814 - Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
Completed NCT05443113 - Young Pectus Excavatum Patients and Genetic Defects
Completed NCT05655741 - Modified Delphi for Genomic Bereavement Care
Completed NCT03847909 - A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 Phase 2
Completed NCT04584528 - Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease N/A
Not yet recruiting NCT06048523 - Prospective Cohort Study of Neurogenetic Diseases N/A
Completed NCT02225522 - Genomic Sequencing in Acutely Ill Neonates N/A
Enrolling by invitation NCT06089954 - Penn Medicine Biobank Return of Results Program N/A
Completed NCT03713333 - Implementing Digital Health in a Learning Health System N/A
Completed NCT03309605 - Phase 1 Study of ELX-02 in Healthy Adult Subjects Phase 1
Recruiting NCT05499091 - Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN N/A
Completed NCT04556487 - Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Completed NCT04556500 - Turkish Version of the Affordance in the Home Environment for Motor Development-Toddler (AHEMD-T)
Recruiting NCT02551081 - Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units